Employment and development
In the 89th Lecture of the "Career and Life" Series, Liu Cheng, the founder, chairman, and CEO of a prominent bioscience enterprise, recounted his odyssey in pursuit of his dream to vanquish cancer. Liu reminisced about his college years and the arduous hurdles he surmounted to launch his company, which has evolved from a fledgling startup into a major force in the bioscience arena. He expounded on his two-pronged strategy for combating cancer: detection and eradication. Back in 2016, Liu's team unearthed a more precise approach to cancer cell detection by scrutinizing cellular constituents. It also achieved a milestone in cancer treatment by successfully enhancing the efficacy of CAR-T therapy for eliminating cancer cells, even accomplishing the first-ever cure of a liver cancer patient. His inspiring discourse spurred students to pose questions and express their perspectives regarding bioscience career paths. The event culminated with Professor Pan commending the students for their enthusiastic participation and active involvement.
The school invited Sheldon Schuster to give the 90th lecture in the series entitled, "Graduate Programs for the Life Science Industry.". With his expertise in life science and genomic medicine, he introduced the MBS concept. Led by Dean Xuemei Chen, faculty members were present.
Schuster shared his post - 2003 contributions in education and entrepreneurship. The MBS program he presented aims to train well-rounded experts. He talked about program improvements and, based on his 15-year biotech incubator experience, gave insights into startups.
He emphasized the importance of China-US economic differences and first-year projects with companies. Also mentioned were MBS projects and China's entrepreneurship potential, praising students.
His speech spurred discussions. Later, he interacted with the audience.
